‹ All Posts
CA Barkha Kamra

16 hours ago · SEBI Registration INH000021164

Venky's (India) Ltd Commences Production at New Kesurdi Unit

Venky’s (India) Ltd VENKEYS has announced the commencement of commercial production at its newly established manufacturing facility in Kesurdi, Maharashtra, marking an important milestone in the company’s capacity expansion strategy. The project involves a total investment of approximately ₹67 crore and is aimed at strengthening the company’s presence in the Animal Health Products (AHP) segment. Key Highlights: * Capacity Expansion: The new manufacturing unit is expected to enhance production capabilities, improve operational efficiency and support increasing demand for animal healthcare products. * Growth Outlook: Management anticipates 15%–20% volume growth in the AHP segment, indicating confidence in the segment’s demand potential and the company’s ability to expand its market reach. * Strategic Importance: The facility could help Venky’s strengthen its product availability, streamline supply chains and reduce dependence on existing manufacturing capacities. * Revenue Potential: Higher production volumes may translate into incremental revenue growth as capacity utilisation improves, subject to market demand and product realisations. * Profitability Impact: Improved operating leverage and economies of scale could support margins over the medium term. However, depreciation, operating expenses and the pace of capacity utilisation will influence actual profitability. Overall View: Positive for the Medium to Long Term. Investors should monitor capacity utilisation, incremental AHP revenue, segment margins and management’s execution against its growth expectations. The announcement is operationally encouraging, although the precise earnings contribution remains to be established.

#StockInNews#WatchOutFor
241 likes·85 comments